Related Experiment Videos

A modified liquid phase (LP) blocking ELISA used to assess type O foot-and-mouth disease virus antigenic variation in

R A Lunt1, W Linchongsubongkoch, L J Gleeson

  • 1CSIRO Australian Animal Health Laboratory, Geelong, Vic., Australia.

Veterinary Microbiology
|September 1, 1994
PubMed

Insights

Foot-and-mouth disease (FMD) viruses in Thailand showed antigenic differences from reference strains. This suggests current vaccines may offer reduced efficacy against circulating FMD virus types.

Area of Science:

  • Veterinary Virology
  • Immunology
  • Epidemiology

Background:

  • Foot-and-mouth disease (FMD) poses a significant threat to livestock globally.
  • Type O FMD viruses are endemic in Southeast Asia, including Thailand.
  • Monitoring antigenic drift in FMD viruses is crucial for vaccine effectiveness.

Purpose of the Study:

  • To assess the antigenic relationship between field strains of type O FMD virus isolated in Thailand (1986-1989) and established reference strains.
  • To evaluate potential reductions in vaccine efficacy due to antigenic variations in circulating FMD viruses.

Main Methods:

  • Liquid-phase blocking enzyme-linked immunosorbent assay (LP ELISA) was employed to compare field and reference FMD virus strains.
  • Serum neutralization titres and associated 'r' values were calculated to quantify antigenic similarity.
  • Interpolation techniques were utilized to enhance the precision of 'r' value estimations.

Main Results:

  • Mean 'r' values indicated antigenic differences between field isolates and reference viruses (O BKK/60 and O NPT/65).
  • A significant percentage of field viruses (41% vs. O BKK/60, 31% vs. O NPT/65) exhibited 'r' values below 0.4, suggesting notable antigenic divergence.
  • Only two viruses showed substantial differences (r < 0.20) to the O BKK/60 reference strain.

Conclusions:

  • Antigenic differences exist between the studied type O FMD field viruses and reference strains used in Thailand.
  • These antigenic variations may compromise the efficacy of existing FMD vaccines.
  • Continuous antigenic surveillance of FMD viruses is essential for maintaining effective disease control strategies.

Related Concept Videos